Purpose

The OCS™ Heart System will be used to preserve and assess donor hearts that do not meet current standard donor heart acceptance criteria for transplantation in this continued access protocol.

Condition

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Criteria


Inclusion Criteria (DONOR):

At least one of the following:

- Expected total cross-clamp time of ≥ 4 hours

- Expected total cross-clamp time of ≥ 2 hours PLUS one or more of the following risk
factors Donor age 45-55 years, inclusive, with no coronary catheterization data; or
Donor age ≥ 55 years; or Left ventricular septal or posterior wall thickness of >12
mm, but ≤ 16 mm; or Reported down time of ≥ 20 min, with stable hemodynamics at time
of final assessment; or Left heart ejection fraction (EF) ≥ 40%, but ≤ 50% at time of
acceptance of offer; or Donor angiogram with luminal irregularities with no
significant CAD (≤ 50%); or History of carbon monoxide poisoning with good cardiac
function at time of donor assessment; or Social history of alcoholism with good
cardiac function at time of donor assessment; or History of diabetes without
significant CAD (≤ 50%) on angiogram.

Exclusion

- CAD with > 50% stenosis on angiogram, or

- Cardiogenic shock or myocardial infarction, or

- EF consistently < 40%, or

- Significant valve disease except for competent bicuspid aortic valve.

Eligibility Criteria (RECIPIENT)

- Registered primary heart transplant candidate

- Age >18 years old

- Written informed consent. Exclusion

- Prior solid organ or bone marrow transplant

- Chronic use of hemodialysis or renal replacement therapy for diagnosis of chronic
renal insufficiency requiring dialysis

- Multi-organ transplant.

Study Design

Phase
N/A
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Primary Purpose
Treatment
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
OCS Preservation
  • Device: OCS Heart System
    The OCS Heart System preserves the heart in a near-physiological, beating state by perfusing the heart with a warmed, donor-blood based perfusate that is supplemented with nutrients and oxygen in a controlled and protected environment

More Details

Status
Completed
Sponsor
TransMedics

Study Contact

Detailed Description

To provide additional data evaluating the safety and effectiveness of the OCS™ Heart System to preserve and assess donor hearts that do not meet current standard donor heart acceptance criteria (as identified above) for transplantation to potentially improve donor heart utilization for transplantation at a range of transplant centers in the U.S. and to permit patients and physicians access to the OCS Heart System while a PMA application is under preparation and review.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.